1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Dtp scripts/data

Discussion in 'Iroko' started by anonymous, Dec 13, 2016 at 12:08 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Anyone wondering where our dtp scripts are going???
     
  2. anonymous

    anonymous Guest

    No where, fast!
     
  3. anonymous

    anonymous Guest

    clearly you weren't listening on the 7,000 Iroko Cares conference calls set up to express affection and gratitude for home office people
     
  4. anonymous

    anonymous Guest

    I was getting my hair done with CES those days.
     
  5. anonymous

    anonymous Guest

    This is an ongoing problem. If you think it isn't, you aren't managing your business. Compare ALL data sources to see discrepancies!!
     
  6. anonymous

    anonymous Guest

    One for the rep, five for the company. One for the rep, four for the company. Rinse and repeat. Wake up little children.